Nanotechnology

[shmoopy38]

MFIC's strong fundamentals:

MFIC is on the OTCBB and is a world class leader in the manufacturing of nanotech capital equipment for the production of nanomaterials and nanoparticles. Its customer base is Fortune 500 cos. and 80% of sales are to biopharmaceutical companies. MFIC's products are found mentioned in thousands of patents issued to major multinational corporations. MFIC is having a strong operational rebound in 2006 after nice profitable growth in 2003 and 2004 and a loss in 2005. The co. is well capitalized with very little bank debt and is cash flow positive. The co. only has 10 million shares outstanding with the CEO and Pfizer controlling about 25%. The market cap is a ridiculously low $18 Million which is 1/10th of what many nanotech stocks with weaker fundamentals are trading at.

Based on the huge 4th quarter sales numbers released this week I am estimating that MFIC could earn at least 10 cents per share in Q4. With a very thin float this could mean a huge price gain for the stock price.

There is one broker that follows MFIC, Taglich Bros., which projected the co. booking $3.8 Million in sales and .01 in EPS in Q4. They will have to significantly increase its numbers in order to remain credible.

I am looking forward to Monday's interview with the CEO which will be simulcast on the Web for additional clues as to what to expect in Q4 and beyond.

Company contacts are Irwin Gruverman, CEO and Jack Swig, General Counsel and Investor Relations. Excellent information available at www.mficcorp.